欢乐颂

CVS removing decongestant from shelves after FDA panel says it's ineffective_我的网站

一 |     编辑观点：《死神》井上织姬在动画最终章动画中加入大量原创剧情，终于迎来真正属于自己的高光，那个被吐槽多年的“花瓶”，这次竟站到了最终BOSS面前。原作漫画中，千年血战篇最终决战阶段，织姬最重要的作用之一，就是配合月岛秀九郎修复一护被斩断的天锁斩月，为一护继续挑战友哈巴赫创造条件。    CVS Health is planning to remove one type of a common decongestant from shelves after an advisory committee to the U.S. Food and Drug Administration said it was ineffective earlier this year.The products contain the oral formulation of phenylephrine (PE), which is found in several over-the-counter (OTC) medications.Although PE has been used as a decongestant for nearly a century, experts have been questioning its efficacy for years.The FDA Nonprescription Drugs Advisory Committee unanimously voted in September that PE did not improve nasal congestion any more than a placebo at the dosage given for OTC use.In response, CVS said it is removing products, in which PE is the only active ingredient from store shelves. This means products like Dayquil, which used a combination of active ingredients, will remain available for purchase."We are aware of the FDA Advisory Committee's position on oral phenylephrine (PE) and will follow direction from the FDA to ensure products we sell comply with all laws and regulations," CVS Health said in a statement. "We are removing certain oral cough and cold products that contain phenylephrine as the only active ingredient from CVS Pharmacy stores. Other oral cough and cold products will continue to be offered to meet consumer needs."CVS did not give specifies on brands that will be removed.The FDA told ABC News it has not yet determined whether it no longer considers PE to be a safe and effective medication and has not ordered the product to be removed from shelves. CVS's move is voluntary."The FDA has no further information to provide at this time regarding the timing of any decision the agency may make following the advisory committee meeting," the federal health agency said.The Consumer Healthcare Products Association told ABC News that the advisory committee's recommendation is a non-binding decision and not a change in regulation."FDA is currently in the process of reviewing the regulatory status of oral phenylephrine (PE) following September's advisory committee meeting," CHPA said in a statement. "Until FDA makes a determination on the committee's recommendation, oral PE remains a Category 1 OTC ingredient, which is generally recognized as safe and effective."Concerns were first raised about PE in 2007. Since then, evidence has accumulated showing that the drug offers little to no relief for nasal congestion.Experts believe this is because the body processes the drug before it reaches the nasal passages where it needs to work.It's unclear if other major retail pharmacy chains will follow in CVS's footsteps.Walgreens Boots Alliance would not disclose whether it was planning to remove products with PE from store shelves and said it would defer to the FDA."Walgreens follows FDA regulations. We are closely monitoring the situation and actively partnering with the Walgreens Office of Clinical Integrity and suppliers on appropriate next steps," a Walgreens spokesperson told ABC News.Other major pharmacy chains including Albertsons, Costco and Kroger did immediately reply to ABC News' request for comment. Walmart did not have an answer immediately available.ABC News' Sasha Pezenik and Sony Salzman contributed to this report.。    该角色也因后期戏份偏辅助，被不少读者贴上“花瓶”标签。故事最终，织姬与一护成婚，两人还有了儿子黑崎一勇。但动画版这次明显不打算这么收场。在原作者久保带人监修下，动画对最终决战进行了大量补充和调整。面对友哈巴赫几乎碾压全场的绝境，织姬迎来全新形态，挖掘了“万象的拒绝”这一能力。

二 | 这一次，她拒绝的不只是眼前发生的某件事情，而是开始拒绝自身“弱小的存在”。    随后，织姬甚至将能力直接指向友哈巴赫，试图否定这个最终BOSS本身的存在。而面对如此强大的敌人，她最终选择以自己为代价，与友哈巴赫同归于尽。最后一幕更是把情绪拉满。织姬回眸告别，说出一句“再见，黑崎君”，随后ED直接切入，该片段被大量观众称作“封神”名场面毕竟过去这么多年，织姬一直有着相当复杂的粉丝评价。喜欢她的人认为她的能力设定非常有潜力，不喜欢的人则觉得她在后期逐渐沦为围绕一护行动的辅助角色，“花瓶”这个标签也因此跟了她很久。

三 | 而这一次，动画直接用一场最终BOSS级别的战斗，把这个争议重新摆到了观众面前。    当然，这也引出了一个很有意思的问题：这到底是久保带人终于意识到原作对织姬的刻画不够，借动画把当年的遗憾补回来，还是单纯为了让最终决战更加精彩？毕竟《死神》漫画完结已经多年，如今动画拥有更充足的制作空间，也有作者本人参与监修，能够重新调整当年因为连载节奏、篇幅等原因没能充分展开的剧情。织姬这次获得如此重量级的原创戏份，显然不只是简单加几分钟战斗画面那么简单。从观众反馈来看，这种改变也确实击中了不少老粉的情怀。有人感慨，等了这么多年终于看到井上织姬真正爆种；也有人认为，这才是女主角应该有的待遇，而不是一直站在一护身后。当然，也有玩家提出另一个问题：如果一个角色过去一直被认为是“花瓶”，现在突然通过一次超规格爆发直接和最终BOSS同归于尽，这种强化究竟算不算真正意义上的角色成长？你觉得这次井上织姬的原创剧情封神了吗？是久保带人终于给女主补票，还是单纯的为爱爆种？评论区聊聊。

Current article:http://89089l3.mengruanpianchengji.cyou/list_xbdd5aq/49zt63.html

Published on:16:17:14